{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:27:40Z","timestamp":1789759660592,"version":"4.0.1"},"reference-count":186,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2020,8,2]]},"DOI":"10.1080\/1744666x.2020.1798230","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T06:58:33Z","timestamp":1595487513000},"page":"787-811","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":28,"title":["The current status of biological treatment for uveitis"],"prefix":"10.1080","volume":"16","author":[{"given":"Carla","family":"Gaggiano","sequence":"first","affiliation":[{"name":"Surgery and Neurosciences, University of Siena","place":["Siena, Italy"]},{"name":"University of Siena","place":["Siena, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Sota","sequence":"additional","affiliation":[{"name":"Surgery and Neurosciences, University of Siena","place":["Siena, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Gentileschi","sequence":"additional","affiliation":[{"name":"Surgery and Neurosciences, University of Siena","place":["Siena, Italy"]},{"name":"Surgery and Neurosciences, University of Siena","place":["Siena, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Caggiano","sequence":"additional","affiliation":[{"name":"Surgery and Neurosciences, University of Siena","place":["Siena, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Grosso","sequence":"additional","affiliation":[{"name":"University of Siena","place":["Siena, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Tosi","sequence":"additional","affiliation":[{"name":"Surgery and Neurosciences, University of Siena","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Frediani","sequence":"additional","affiliation":[{"name":"Surgery and Neurosciences, University of Siena","place":["Siena, Italy"]},{"name":"Surgery and Neurosciences, University of Siena","place":["Siena, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7352-1275","authenticated-orcid":false,"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[{"name":"Surgery and Neurosciences, University of Siena","place":["Siena, Italy"]},{"name":"Surgery and Neurosciences, University of Siena","place":["Siena, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Fabiani","sequence":"additional","affiliation":[{"name":"Surgery and Neurosciences, University of Siena","place":["Siena, Italy"]},{"name":"Surgery and Neurosciences, University of Siena","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,8]]},"reference":[{"issue":"8","key":"e_1_3_4_3_1","first-page":"478","article-title":"Impact of uveitis on quality of life: a prospective study from a tertiary referral rheumatology-ophthalmology collaborative uveitis center in Italy","volume":"19","author":"Fabiani C","year":"2017","unstructured":"Fabiani C, Vitale A, Orlando I, et al. Impact of uveitis on quality of life: a prospective study from a tertiary referral rheumatology-ophthalmology collaborative uveitis center in Italy. Isr Med Assoc J. 2017;19(8):478\u2013483.","journal-title":"Isr Med Assoc J"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.03.029"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2016.1196713"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200107000-00005"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.03.057"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273940801899822"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2012.747524"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.02.019"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.73.2.155"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2013.03.027"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2017-134891"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2015.07.001"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-018-0949-4"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0502-y"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067210901900616"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05497-6"},{"issue":"2","key":"e_1_3_4_19_1","first-page":"301","article-title":"Efficacy of anti-tumour necrosis factor-\u03b1 monoclonal antibodies in patients with non-infectious anterior uveitis","volume":"37","author":"Fabiani C","year":"2019","unstructured":"Fabiani C, Vitale A, Rigante D, et al. Efficacy of anti-tumour necrosis factor-\u03b1 monoclonal antibodies in patients with non-infectious anterior uveitis. Clin Exp Rheumatol. 2019;37(2):301\u2013305.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.09.048"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.11.017"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020888"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-014581"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2009.203"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.11.032"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150057"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509852"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31339-3"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.12.039"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-302292"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2015.1134581"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2007.0104"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.092585"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.02.018"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-301401"},{"issue":"1","key":"e_1_3_4_36_1","article-title":"Efficacy and safety of adalimumab in Beh\u00e7et\u2019s disease-related uveitis: a multicenter retrospective observational study","volume":"36","author":"Fabiani C","year":"2017","unstructured":"Fabiani C, Vitale A, Emmi G, et al. Efficacy and safety of adalimumab in Beh\u00e7et\u2019s disease-related uveitis: a multicenter retrospective observational study. Clin Rheumatol. 2017;36(1):183\u20109.","journal-title":"Clin Rheumatol"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.0603"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-310733"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.02.020"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1411518"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-020-00697-4"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4069-3"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00406-8"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00721-8"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-5-200403020-00025"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01292-7"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05514.x"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.6.637"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D361"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.037192"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.7.903"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.141"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001269"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21231"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-008-0606-8"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1423.050"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1213-z"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq366"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1391297"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.04.042"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.6.845"},{"issue":"5","key":"e_1_3_4_62_1","article-title":"Multicenter study of infliximab for refractory uveoretinitis in Beh\u00e7et disease","volume":"130","author":"Okada AA","year":"2012","unstructured":"Okada AA, Goto H, Ohno S, et al. Multicenter study of infliximab for refractory uveoretinitis in Beh\u00e7et disease. Arch Ophthalmol. 2012;130(5):592\u20108.","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1793-7"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39667"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2018.1498110"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4133-z"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4228-6"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41026"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu266"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.05.019"},{"issue":"2","key":"e_1_3_4_71_1","first-page":"320","article-title":"Golimumab treatment for complicated uveitis","volume":"31","author":"Miserocchi E","year":"2013","unstructured":"Miserocchi E, Modorati G, Pontikaki I, et al. Golimumab treatment for complicated uveitis. Clin Exp Rheumatol. 2013;31(2):320\u2013321.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180312"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.03.002"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1351573"},{"issue":"4","key":"e_1_3_4_75_1","first-page":"680","article-title":"Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis","volume":"37","author":"Tosi GM","year":"2019","unstructured":"Tosi GM, Sota J, Vitale A, et al. Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis. Clin Exp Rheumatol. 2019;37(4):680\u2013683.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2013.844265"},{"key":"e_1_3_4_77_1","first-page":"2014","article-title":"Golimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experience","volume":"717598","author":"Cordero-Coma M","year":"2014","unstructured":"Cordero-Coma M, Calvo-R\u00edo V, Ad\u00e1n A, et al. Golimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experience. Mediators Inflamm. 2014;717598:2014.","journal-title":"Mediators Inflamm"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-016-0239-y"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2014.967779"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22848"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2017.1285857"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/00124743-200106000-00008"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.iae.0000242843.02952.46"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-009-0691-6"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.7.925"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22918"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/471319"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.103192"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02187-y"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.4.437"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.052092"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210931"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.969368"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00104"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.82.5.488"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.4.423"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2003.09.005"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.4.467"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2015.1133835"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1606256"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.iae.0000244265.75771.71"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.03.001"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.061119"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oftal.2016.11.018"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2015.1125508"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2013.05.002"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-006-0346-y"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.101550"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.03.050"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.3"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1384026"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.04.044"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2015.12.032"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1327602"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.12.004"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2013.8179"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000427"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-017-3603-3"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2781-1"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-304686"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S35521"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1177\/1120672119845224"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2010.01546.x"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001563"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1159\/000486791"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2005.05.007"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3672-z"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005516"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040391"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13015"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex480"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.06.050"},{"issue":"4","key":"e_1_3_4_133_1","first-page":"S75","article-title":"Tocilizumab in severe and refractory non-infectious uveitis","volume":"32","author":"Papo M","year":"2014","unstructured":"Papo M, Bielefeld P, Vallet H, et al. Tocilizumab in severe and refractory non-infectious uveitis. Clin Exp Rheumatol. 2014;32(4):S75\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001690"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.08.019"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-019-0179-6"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110170"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.09.044"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.109"},{"key":"e_1_3_4_140_1","first-page":"1542","article-title":"Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist","volume":"15","author":"Tsai ML","year":"2009","unstructured":"Tsai ML, Horng CT, Chen SL, et al. Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist. Mol Vis. 2009;15:1542\u20131552.","journal-title":"Mol Vis"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.6.3736"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3527-z"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2015.06.018"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1421233"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2443-8"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3004-0"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.13538"},{"issue":"3","key":"e_1_3_4_148_1","first-page":"152","article-title":"Anakinra for resistant Beh\u00e7et uveitis: why not?","volume":"31","author":"Emmi G","year":"2013","unstructured":"Emmi G, Silvestri E, Cameli AM, et al. Anakinra for resistant Beh\u00e7et uveitis: why not? Clin Exp Rheumatol. 2013;31(3):152\u2013153.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"e_1_3_4_149_1","first-page":"S172","article-title":"Reply: anti-IL1 blocking agents in drug-resistant Beh\u00e7et\u2019s syndrome: our little case series","volume":"32","author":"Emmi G","year":"2014","unstructured":"Emmi G, Silvestri E, Ciucciarelli L, et al. Reply: anti-IL1 blocking agents in drug-resistant Beh\u00e7et\u2019s syndrome: our little case series. Clin Exp Rheumatol. 2014;32(4):S172.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"e_1_3_4_150_1","first-page":"S171","article-title":"Efficacy of anakinra in refractory Beh\u00e7et\u2019s disease sacroiliitis","volume":"32","author":"Caso F","year":"2014","unstructured":"Caso F, Rigante D, Vitale A, et al. Efficacy of anakinra in refractory Beh\u00e7et\u2019s disease sacroiliitis. Clin Exp Rheumatol. 2014;32(4):S171.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13337"},{"key":"e_1_3_4_152_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev197"},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.1159\/000358125"},{"key":"e_1_3_4_154_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201383"},{"key":"e_1_3_4_155_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3506-4"},{"key":"e_1_3_4_156_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2018.1511810"},{"key":"e_1_3_4_157_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4119-x"},{"issue":"9","key":"e_1_3_4_158_1","first-page":"2016","article-title":"Requirement of B7-mediated costimulation in the induction of experimental autoimmune anterior uveitis","volume":"42","author":"Shao H","year":"2001","unstructured":"Shao H, Woon MD, Nakamura S, et al. Requirement of B7-mediated costimulation in the induction of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci. 2001;42(9):2016\u20132021.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_159_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.9.5041"},{"key":"e_1_3_4_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2015.08.012"},{"key":"e_1_3_4_161_1","first-page":"5190","article-title":"A phase I\/II dose-ranging, randomized clinical trial of abatacept (Orencia) in the treatment of refractory non-infectious uveitis: preliminary results","volume":"54","author":"Suhler E","year":"2013","unstructured":"Suhler E, Giles T, Hanel S, et al. A phase I\/II dose-ranging, randomized clinical trial of abatacept (Orencia) in the treatment of refractory non-infectious uveitis: preliminary results. Invest Ophthalmol Vis Sci. 2013;54:5190.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_162_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20115"},{"key":"e_1_3_4_163_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151389"},{"key":"e_1_3_4_164_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140410"},{"key":"e_1_3_4_165_1","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.194339"},{"key":"e_1_3_4_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.05.014"},{"key":"e_1_3_4_167_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1585"},{"key":"e_1_3_4_168_1","doi-asserted-by":"publisher","DOI":"10.1080\/030097402320318387"},{"key":"e_1_3_4_169_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-1390"},{"issue":"62","key":"e_1_3_4_170_1","first-page":"52ra72","article-title":"Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis","volume":"2","author":"Hueber W","year":"2010","unstructured":"Hueber W, Patel DD, Dryja T, et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med. 2010;2(62):52ra72.","journal-title":"Sci Transl Med"},{"key":"e_1_3_4_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.09.040"},{"key":"e_1_3_4_172_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.12.033"},{"key":"e_1_3_4_173_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12527"},{"key":"e_1_3_4_174_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz167"},{"key":"e_1_3_4_175_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1569245"},{"key":"e_1_3_4_176_1","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.4.4.294"},{"key":"e_1_3_4_177_1","doi-asserted-by":"publisher","DOI":"10.2174\/1566524015666150731100012"},{"key":"e_1_3_4_178_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.5934"},{"key":"e_1_3_4_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2018.12.001"},{"key":"e_1_3_4_180_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1605453"},{"key":"e_1_3_4_181_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04875-w"},{"key":"e_1_3_4_182_1","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2017.16112"},{"issue":"6","key":"e_1_3_4_183_1","first-page":"111","article-title":"Biosimilar infliximab for Beh\u00e7et\u2019s syndrome: a case series","volume":"37","author":"Dincses E","year":"2019","unstructured":"Dincses E, Esatoglu SN, Ozguler Y, et al. Biosimilar infliximab for Beh\u00e7et\u2019s syndrome: a case series. Clin Exp Rheumatol. 2019;37(6 Suppl 121):111\u2013115.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_184_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-018-1970-3"},{"key":"e_1_3_4_185_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.10.002"},{"key":"e_1_3_4_186_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01468"},{"key":"e_1_3_4_187_1","first-page":"8294560","article-title":"New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy","volume":"2020","author":"Sota J","year":"2020","unstructured":"C, Sota J, Sainz-de-la-Maza M, et al. New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy. Mediators Inflamm. 2020;2020:8294560.","journal-title":"Mediators Inflamm"},{"key":"e_1_3_4_188_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8294560"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2020.1798230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T20:15:18Z","timestamp":1770927318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2020.1798230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":186,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8,2]]}},"alternative-id":["10.1080\/1744666X.2020.1798230"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2020.1798230","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-05-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}